Age, median (IQR)
|
37 (32,45)
|
30 (25, 35)
|
35 (30, 42)
|
31 (25, 38)
|
Informal settlement¶
|
404 (38%)
|
859 (39%)
|
869 (39%)
|
390 (39%)
|
Married to study partner
|
866 (81%)
|
1627 (73%)
|
1636 (74%)
|
864 (81%)
|
Cohabiting with study partner
|
1002 (93%)
|
1970 (89%)
|
1983 (89%)
|
1000 (93%)
|
>8 years of education completed
|
512 (48%)
|
901 (41%)
|
1157 (52%)
|
401 (37%)
|
Any income
|
638 (59%)
|
546 (25%)
|
1331 (60%)
|
280 (26%)
|
CD4, median, cells/mm3 (IQR)
| | |
-
|
-
|
Enrollment
|
426 (334, 571)
|
481 (354, 664)
| | |
Final visit
|
394 (276, 544)
|
437 (312, 617)
| | |
HIV-1 plasma RNA, median, log10 copies/mL (IQR)
| | |
-
|
-
|
Enrollment
|
4.2 (3.5, 4.8)
|
3.8 (3.0, 4.4)
| | |
Final visit
|
4.4 (3.6, 5.0)
|
4.0 (3.2, 4.7)
| | |
Ever on ART over follow up
|
112 (10%)
|
178 (8%)
|
-
|
-
|
Highest WHO stage of HIV-1
| | |
-
|
-
|
< 3
|
806 (75%)
|
1720 (77%)
| | |
3
|
243 (23%)
|
436 (20%)
| | |
4
|
24 (2%)
|
66 (3%)
| | |